Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2006
12/27/2006EP1379515B1 Lipid lowering biphenylcarboxamides
12/27/2006EP1358209B1 Crystallization of igf-1
12/27/2006EP1354047B1 Methods for screening compounds that modulate lipid metabolism
12/27/2006EP1345895B1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
12/27/2006EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
12/27/2006EP1282687B1 Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same
12/27/2006CN1886423A Glycoisoforms of adiponectin and uses thereof
12/27/2006CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
12/27/2006CN1886401A Benzoyl amino pyridil carboxylic acid derivatives as gluokinase activators
12/27/2006CN1886392A Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder
12/27/2006CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring
12/27/2006CN1886383A Process for the preparation of amorphous rosuvastatin calcium
12/27/2006CN1886377A Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (GLK) activators
12/27/2006CN1886365A Novel salicylic anilides
12/27/2006CN1886364A Selective peroxisome proliferator activated receptor modulators
12/27/2006CN1886142A Methods and means for modulating lipid metabolism
12/27/2006CN1886129A Use of pentadienoic acid derivates for treatment of hyperuricemia
12/27/2006CN1886124A Method of inhibiting remnant lipoprotein production
12/27/2006CN1884305A Modified glycose/biose as meal fiber and fat-reducing product
12/27/2006CN1884278A Glucagon-like peptide-1 receptor regulator, its preparation method and uses
12/27/2006CN1884265A Aporphine for treating diabetes mellitus and aporphine compounds
12/27/2006CN1883701A Ciliary nerves nutrilite composition having long-time stability
12/27/2006CN1883674A 'Jiang Tang Ning' preparation for treating diabetes and preparation method thereof
12/27/2006CN1883660A Blood fat-reducing Chinese medicine and preparation method thereof
12/27/2006CN1883656A Blood sugar-lowering enteric coated capsule and preparation method thereof
12/27/2006CN1883653A Chinese proprietary medicine for regulating blood sugar and application thereof
12/27/2006CN1883650A Health-caring essence and preparation method thereof
12/27/2006CN1883623A A blood fat-decreasing compound Chinese medicine and preparation method thereof
12/27/2006CN1883621A Medicine for treating angiitis sore of diabetic foot and method for preparing same
12/27/2006CN1883617A A Chinese medicine for treating hypertension and hyperlipemia and method for preparing same
12/27/2006CN1883590A Method for preparing ganoderma spore oil
12/27/2006CN1883587A Preparation of 'Xin Ke Shu' tablet for treating coronary heart disease
12/27/2006CN1883580A A compound Chinese medicinal preparation
12/27/2006CN1883569A Chinese medicinal health product
12/27/2006CN1883541A A Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease, its preparation method and use
12/27/2006CN1883535A A pharmaceutical composition containing rhodiola root, its preparation method and use
12/27/2006CN1883515A Bee pollen soft capsule and preparation method thereof
12/27/2006CN1883514A Bee pollen nutrition oral liquid and preparation method thereof
12/27/2006CN1883513A Method for separating active blood sugar-lowering substances from silkworm powder
12/27/2006CN1883512A A method for preparing silkworm powder
12/27/2006CN1883510A A method for preparing hirudin by making leech bloodsucker as raw material and application thereof
12/27/2006CN1883501A Application of low molecular citrus pectin in regulation of blood sugar, blood fat and improvement of fatty liver
12/27/2006CN1883476A Orally administered medicinal composition for treating diabetes
12/27/2006CN1883473A An enteric coated tablet of dulouxetine
12/27/2006CN1883472A Orally disintegrating tablet of ginkgolide and preparation method thereof
12/27/2006CN1883434A A weight-reducing method utilizing points-pressing and Chinese medicinal preparation thereof
12/27/2006CN1883306A Blood fat-lowering chewing tablet of housefly larvae chitooligosaccharides and method for making same
12/27/2006CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient
12/27/2006CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry
12/27/2006CN1291735C Chinese medicine dripping pill preparation for promoting blood circulation and removing blood stasis, promoting Qi circulation and relieving pain
12/27/2006CN1291722C Use of oligoxylose in preparation of medicine for treating diabetes
12/27/2006CN1291721C Use of allose alcohol in preparation of medicine for diabetes
12/27/2006CN1291709C Sugar-free type blood-fat-lowering granule, and its preparation method
12/27/2006CN1291665C Fat-reducing health beverage
12/26/2006US7154001 Formate salt of O-desmethyl-venlafaxine
12/26/2006US7153997 N-hydroxyphenoxyphenyl derivatives of glycine or valine, e.g., N-[3,5-Dichloro-4-(4-hydroxy-3-isopropyl-5-methylphenoxy)benzoyl]glycine; treating metabolic disorders or diseases dependent upon the expression of a T3 regulated gene
12/26/2006US7153963 Phenylalanine derivatives
12/26/2006US7153961 Hydrate of a benzenesulfonate salt of 4-(bis(2-methoxyethyl)amino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-[1,5-a]-pyrazolo-1,3,5-triazine; physical and chemical properties that are both physiologically acceptable and suitable for preparing reproducible pharmaceutical formulations
12/26/2006US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives
12/26/2006US7153881 Compounds acting as melanocortin receptor ligands
12/26/2006US7153878 Substituted thiazoles and oxazoles, e.g., 4-{1-[4-[2-(2-Chloro-6-fluoro-phenyl)-ethyl]-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethylsulfanyl}-2-methyl-phenoxy)-acetic acid; treating atherosclerosis and diabetes and creating Syndrome X
12/26/2006US7153877 Chromium bound to niacin and three compounds from the group consisting of (-) hydroxycitric acid, zinc (particularly zinc methionine), trans-reseveratrol, gymnernic acid, selenium, an anthocyanidin, allicin, and fenugreek.
12/26/2006US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety
12/26/2006US7153861 5,6 -Trimethylenepyrimidin-4-one compounds
12/26/2006US7153850 Lactam compounds and pharmaceutical use thereof
12/26/2006US7153822 Compositions and methods for modulating connexin hemichannels
12/21/2006WO2006135795A1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
12/21/2006WO2006135667A1 Imidiazo -and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
12/21/2006WO2006135280A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
12/21/2006WO2006135084A1 Prophylactic or therapeutic agent for steatohepatitis or fatty liver
12/21/2006WO2006135083A1 Prophylactic or therapeutic agent for visceral fat syndrome
12/21/2006WO2006135080A1 Thienopyrimidine derivative
12/21/2006WO2006134604A1 Combination composition of cholesterol absorption inhibitor and 3-hydroxy-3-methylglutaryl-coenzyme a (hmg-coa) reductase inhibitor
12/21/2006WO2006134481A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
12/21/2006WO2006134340A2 Oxyntomodulin analogues and their effects on feeding behaviour
12/21/2006WO2006134317A1 Oxadiazole derivatives as dgat inhibitors
12/21/2006WO2006134150A1 Benzofuranyl derivatives as 5-ht6-receptor inhibitors
12/21/2006WO2006134040A1 Anthranilic acid derivatives
12/21/2006WO2006133926A1 Pyrazole derivates as cannabinoid receptor modulators
12/21/2006WO2006133533A1 A treatment for short bowel syndrome
12/21/2006WO2006133477A1 Peptides corresponding to human growth hormone
12/21/2006WO2006104997A3 Tartaric acid salts of a dipeptidyl peptidase-iv inhibitor
12/21/2006WO2006097793A3 Compositions capable of facilitating penetration across a biological barrier
12/21/2006WO2006083673A3 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases
12/21/2006WO2006076569A3 Bicyclic heterocycles as cannabinoid receptor modulators
12/21/2006WO2006074432A3 Adiponectin variants
12/21/2006WO2006058303A3 Modulators of muscarinic receptors
12/21/2006WO2006018662A3 Aryl urea derivatives for treating obesity
12/21/2006WO2006014790A3 Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses
12/21/2006WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/21/2006US20060287539 Chemical intermediates for production of sibutramine
12/21/2006US20060287538 Process for the preparation of amorphous calcium salt of atorvastatin
12/21/2006US20060287536 Phenyl-thiophene type vitamin d receptor modulators
12/21/2006US20060287510 Crystallization of IGF-1
12/21/2006US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/21/2006US20060287367 Pyridoxamine for the treatment of diabetic kidney disease
12/21/2006US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders
12/21/2006US20060287338 Metalloproteinase inhibitor compounds
12/21/2006US20060287334 e.g. 8-(4-(4-Fluorobenzyl)-piperazin-1-yl)-3-phenylsulfonylquinoline; serotonin receptor modulator; antidepressant, anxiolytic agent, cognition activator; schizophrenia, obesity, Alzheimer's disease